Cardiol Therapeutics (CRDL) Amortization - Intangibles (2020 - 2021)
Cardiol Therapeutics' (CRDL) quarterly Amortization - Intangibles came in at $17174.4 in Q2 2021, up 12.8% YoY from $15225.3 in Q2 2020, and up 12.8% on a QoQ basis from $15225.3 in Q2 2020.
Cardiol Therapeutics (CRDL) Amortization - Intangibles (2020 - 2021) Analysis & Trends
Cardiol Therapeutics (CRDL) has 2 years of Amortization - Intangibles data on file, last reported at $17174.4 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 17,174.37 |
| Jun 30, 2020 | 15,225.34 |